CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Brentuximab-Vedotin, in vitro

Hansen, Hinrich P ; Trad, Ahmad ; Dams, Maria ; Zigrino, Paola ; Moss, Marcia ; Tator, Maximilian ; Schön, Gisela ; Grenzi, Patricia C ; Bachurski, Daniel ; Aquino, Bruno ; Dürkop, Horst ; Reiners, Katrin S ; von Bergwelt-Baildon, Michael ; Hallek, Michael ; Grötzinger, Joachim ; Engert, Andreas ; Paes Leme, Adriana F ; Pogge von Strandmann, Elke

Oncotarget, 2016-05, Vol.7 (21), p.30523-30535

United States: Impact Journals LLC

Texto completo disponível